Premia 10

Kraj: Nowa Zelandia

Język: angielski

Źródło: Medsafe (Medicines Safety Authority)

Składnik aktywny:

Conjugated estrogens 0.625mg (in core, 3% overage);  ; Medroxyprogesterone acetate 10mg (in coat, 4% overage);  ; Conjugated estrogens 0.625mg (in core, 3% overage)

Dostępny od:

Wyeth (NZ) Ltd

INN (International Nazwa):

Conjugated estrogens 0.625 mg (in core, 3% overage)

Forma farmaceutyczna:

Tablet

Skład:

Active: Conjugated estrogens 0.625mg (in core, 3% overage)   Medroxyprogesterone acetate 10mg (in coat, 4% overage)   Excipient: Calcium phosphate Calcium sulfate Carnauba wax Glyceryl mono-oleate Lactose monohydrate Macrogol 20000 Magnesium stearate Methylcellulose Microcrystalline cellulose Opacode black S-8-27741 Opalux green Povidone Shellac Stearic acid Sucrose Titanium dioxide Active: Conjugated estrogens 0.625mg (in core, 3% overage) Excipient: Calcium phosphate Calcium sulfate Carnauba wax Glyceryl mono-oleate Ink Lactose monohydrate Macrogol 20000 Magnesium stearate Methylcellulose Microcrystalline cellulose Opalux maroon Shellac Stearic acid Sucrose Titanium dioxide

Sztuk w opakowaniu:

Blister pack, Green tablets, 14 tablets

Klasa:

Prescription

Typ recepty:

Prescription

Wyprodukowano przez:

Ayerst Organics Division of Wyeth Canada Inc.

Podsumowanie produktu:

Package - Contents - Shelf Life: Blister pack, Green tablets - 14 tablets -   - Blister pack, Maroon tablets - 14 tablets -   - Blister pack, 1 x (14 + 14), PVC/Al - 28 tablets - 24 months from date of manufacture stored at or below 30°C

Data autoryzacji:

2000-03-24